Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pancreatic Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Squamous Cell 3Rectal Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Adenocarcinoma Of Esophagus 2Tonsillar Neoplasms 1Resectable Esophageal Cancer 1Pharyngeal Neoplasms 1Neoplasms by Site 1Neoplasms 1Muscle Invasive Bladder Cancer 1Melanoma 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Adenosquamous 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

tislelizumab 1Tirapazamine 1Radiotherapy 1Radiation 1Etoposide 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Limited Stage Small Cell Lung Cancer × Chemoradiotherapy × Clear all
NCT04952597 2024-10-26

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer

BeiGene

Phase 2 Completed
126 enrolled 19 charts
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡